Understanding Beckwith-Wiedemann Syndrome: From Diagnosis to Management

Date:
Nov 19, 2020 from 2 p.m. - 3 p.m. (ET)

Speaker: Jennifer M. Kalish, MD PhD, Director, Beckwith-Wiedemann Syndrome Clinic at Children's Hospital of Philadelphia

Overview:

Beckwith-Wiedemann Syndrome (BWS) is an overgrowth and cancer predisposition syndrome and families still face barriers to diagnosis and standard of care management. This virtual lecture will provide up to date information on the current diagnostic and multi-disciplinary disease management practices for BWS, including a review of a newly published clinical pathway for the diagnosis and management of BWS.

Learning Objectives:

Upon completion of this lecture, participants should be able to:

  1. Identify the clinical diagnostic criteria for Beckwith-Wiedemann Syndrome
  2. Classify the molecular etiology of BWS
  3. Review the current management practices for BWS, including new evidence-based clinical pathway for BWS diagnosis and management in the NICU

BWS is a complex disease requiring effective coordination of care among many different pediatric specialties, including genetics, neonatology, plastic surgery, orthodontists, speech pathology, pulmonology, feeding specialists, oncology, endocrinology, orthopedics and gastroenterology. Attendees from any of these disciplines are encouraged to attend this lecture. 

Contact: Shelly Norbury, (856) 397-5588, norburys@chop.edu

Register Today

ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Jenn Kalish, MD, Katie Lockwood, MD (CHOP Talks Course Director) and Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with a commercial interest to disclose.

Note: This session will be recorded and made available on our website. If you would like to ask a question during the event but would like to remain anonymous, please do not use your real name when signing in.

Save the Date for our Deciphering Beckwith-Wiedemann Syndrome Spectrum July 23-25, 2021